Literature DB >> 35152783

Commentary on Aschmann et al: How do we incorporate harms in analyses of randomized trials?

Andrew Vickers1.   

Abstract

Entities:  

Year:  2022        PMID： 35152783      PMCID： PMC9038613          DOI： 10.1177/17407745211068547

Source DB:  PubMed          Journal:  Clin Trials        ISSN： 1740-7745            Impact factor:   2.599


× No keyword cloud information.
  1 in total

1.  Large-scale prevention trials could provide stronger evidence for decision-makers: Opportunities to design and report with a focus on the benefit-harm balance.

Authors:  Hélène E Aschmann; John J McNeil; Milo A Puhan
Journal:  Clin Trials       Date:  2022-02-13       Impact factor: 2.599
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.